Clinical Trial: Study of UshStat in Patients With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: A Phase I/IIa Dose Escalation Safety Study of Subretinally Injected UshStat®, Administered to Patients With Retinitis Pigmentosa Associated With Usher Syndrome Type 1

Brief Summary:

To evaluate the safety and tolerability of ascending doses of subretinal injections of UshStat in patients with Usher syndrome type 1B.

To evaluate for possible biological activity of UshStat.